학술논문

Protective effect of oltipraz in testicular ischaemia/reperfusion injury: An experimental study.
Document Type
Article
Source
Andrologia. Feb2022, Vol. 54 Issue 1, p1-8. 8p.
Subject
*REPERFUSION injury
*ISCHEMIA
*SPERMATIC cord torsion
*URINARY organ diseases
*SUPEROXIDE dismutase
*ORCHIOPEXY
*THERAPEUTICS
*INTRAPERITONEAL injections
Language
ISSN
0303-4569
Abstract
Testicular torsion is an emergency urological disease, and the treatment is immediate surgery. Despite emergency surgery, testicular damage may occur due to reperfusion. Therefore, a medical treatment to prevent this damage may be a rational idea. We aimed to evaluate the protective effect of oltipraz in testicular ischaemia/reperfusion damage. Twenty‐eight Wistar–Albino rats were randomly divided into four groups. In ischaemia/reperfusion group, testicular torsion was executed, and orchiectomy was done 4 hr after detorsion with no treatment. Second group performed torsion; intraperitoneal 50 mg/kg oltipraz was applied 30 min before detorsion, and orchiectomy was performed 4 hr after detorsion. Third group applied torsion; intraperitoneal 150 mg/kg oltipraz was applied 30 min before detorsion, and orchiectomy was performed 4 hr after detorsion. Last one was the sham group. We evaluated tissue malondialdehyde (MDA), transforming growth factor‐β1 (TGF‐β1), superoxide dismutase (SOD), reduced glutathione (GSH) and Johnsen testicular biopsy score. There was a significant decrease in TGF‐β1, GSH and MDA values in oltipraz treatment groups compared with ischaemia/reperfusion group. Oltipraz treatment has significant protective effect in testicular ischaemia/reperfusion damage. However, more clinical studies are needed to demonstrate appropriate dose and its effects. [ABSTRACT FROM AUTHOR]